Physician profile
William B Kimbrough
NPI 1871772202
$8,611.71
in general payments reported to CMS, 2019-2025
14 companies · $69.42 in 2025
The $69.42 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $5,399 · 2021: $2,167 · 2022: $466 · 2023: $341 · 2024: $26.62 · 2025: $69.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,724.78 | 2020-2022 | |
| Kerecis Limited | $292.51 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $207.39 | 2019-2024 | Renasys Touch, Renasys Go V2 Home, Pico 7 |
| W. L. Gore & Associates, INC. | $96.31 | 2020 | |
| Solventum Corporation | $69.42 | 2025 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Mozarc Medical US LLC | $57.58 | 2023 | Argyle |
| Davol INC. | $34.89 | 2020 | |
| Medtronic, INC. | $27.78 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $25.06 | 2023 | Seglentis |
| Kci USA, INC. | $19.76 | 2021 | |
| Ethicon US, LLC | $18.03 | 2020 | |
| Boston Scientific Corporation | $13.99 | 2021 | |
| Tela Bio, INC. | $13.10 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kimbrough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.